Hoofdnavigatie (Druk op Enter)
Direct naar de inhoud van de pagina (druk op "Enter")
Lijst van andere websites (Druk op Enter)

Commissie milieubeheer, volksgezondheid en voedselveiligheid

ENVICommissievergadering -15:13 / 17:18 - 02-12-2019
 
Download Hulp tonen: on  
 
Vul hieronder uw e-mailadres in indien u de link voor de video toegestuurd wilt krijgen.
 
 
(Disclaimer lezen)
 
 
 
 
Onderwerp
This event is also available on our multidevice player.
Agenda
  • Mon, 2 Dec 2019 15:00 - 17:00
    • 1.0 Adoption of agenda
    • 2.0 Chair’s announcements
    • 3.0 Chair’s announcements concerning coordinators’ recommendations of 6 November and of 25 November 2019
    • 4.0 * Establishment of a framework to facilitate sustainable investment (ECON-ENVI (CJ36)) * Quality of water intended for human consumption (recast) * Minimum requirements for water reuse(ENVI/9/01588) Report back on ongoing interinstitutional negotiations
    • 5.0 Exchange of views with {XMLIT_NAME} Bjørn Hansen, Executive Director of ECHA
    • 6.0 (ENVI/9/01877) Objection pursuant to Rule 111(3): Delegated act on classification, labelling and packaging of substances and mixtures - titanium dioxide
    • 7.0 (ENVI/9/01817) Objection pursuant to Rule 112: Imports of petfood from Saudi-Arabia
    • 8.0 (ENVI/9/01714) Objection pursuant to Rule 112: Imposing special conditions governing the import of feed and food originating in or consigned from Japan following the accident at the Fukushima nuclear power station (D063901)
    • 9.0 (ENVI/9/01882) Objection pursuant to Rule 112: the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (D064213-01)
  • Mon, 2 Dec 2019 17:00 - 18:30
    • In camera
    • 10.0 Coordinators’ meeting
  • Tue, 3 Dec 2019 09:30 - 10:30
    • 11.0 Exchange of views with {XMLIT_NAME} Dr Werner Hoyer, President of the European Investment Bank, on the transformation of part of the bank into a Climate Bank
  • Tue, 3 Dec 2019 10:30 - 12:30
    • *** Electronic vote ***
    • 12.0 (ENVI/9/01877) Objection pursuant to Rule 111(3): Delegated act on classification, labelling and packaging of substances and mixtures - titanium dioxide
    • 13.0 (ENVI/9/01817) Objection pursuant to Rule 112: Imports of petfood from Saudi-Arabia
    • 14.0 (ENVI/9/01714) Objection pursuant to Rule 112: Imposing special conditions governing the import of feed and food originating in or consigned from Japan following the accident at the Fukushima nuclear power station (D063901)
    • 15.0 (ENVI/9/01882) Objection pursuant to Rule 112: the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (D064213-01)
    • 16.0 (ENVI/9/01240) Strategic approach to pharmaceuticals in the environment
    • 17.0 (ENVI/9/01248) COP15 to the Convention on Biological Diversity (CBD) - Kunming (2020)
    • 18.0 (ENVI/9/01217) EU Pollinators Initiative
    • 19.0 (ENVI/9/01218) Enabling the digital transformation of health and care in the Digital Single Market; empowering citizens and building a healthier society
    • Corrigenda (Rule 241)
    • 20.0 (ENVI/9/01996) CORRIGENDUM to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (OJ L 117, 5.5.2017, p. 176) (position of the European Parliament adopted at second reading on 5 April 2017 with a view to the adoption of the above regulation P8_TA(2017)0108) - (10729/4/2016 – C8-0105/2017 – 2012/0267(COD))
    • 21.0 (ENVI/9/01997) CORRIGENDUM to Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1) (position of the European Parliament adopted at second reading on 5 April 2017 with a view to the adoption of the above regulation P8_TA(2017)0107) - (10728/4/2016 – C8-0104/2017 – 2012/0266(COD))
    • *** End of electronic vote ***
    • 22.0 (ENVI/9/01240) Strategic approach to pharmaceuticals in the environment
  • Tue, 3 Dec 2019 14:30 - 18:30
    • Joint debate
    • 23.0 (ENVI/9/01030) 2018 discharge: General budget of the EU - European Commission
    • 24.0 (ENVI/9/00860) 2018 discharge: European Environment Agency (EEA)
    • 25.0 (ENVI/9/00854) 2018 discharge: European Medicines Agency (EMA)
    • 26.0 (ENVI/9/00827) 2018 discharge: European Chemicals Agency (ECHA)
    • 27.0 (ENVI/9/00842) 2018 discharge: European Centre for Disease Prevention and Control (ECDC)
    • 28.0 (ENVI/9/00844) 2018 discharge: European Food Safety Authority (EFSA)
    • * * *
    • 29.0 (ENVI/9/01219) European Year of Greener Cities 2021
    • 30.0 (ENVI/9/00448) Amending Decision No 1313/2013/EU of the European Parliament and of the Council on a Union Civil Protection Mechanism
    • 31.0 Exchange of views with {XMLIT_NAME} the Commission on the evaluation of the Union legislation on blood, tissues and cells
    • 32.0 Any other business
    • 33.0 Next meetings (ENVI(2019)1216_1) Mon, 16 Dec 2019
    • Next meetings (ENVI(2020)0109_1) Thu, 9 Jan 2020